Does HFE Genotype Impact Macrophage Phenotype in Disease Process and Therapeutic Response?

Anne M. Nixon, James R. Connor

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Iron is a critical cofactor involved in many important physiological processes throughout the human body. Therefore, mismanagement of iron can lead to numerous unfavorable effects, such as the generation of toxic reactive oxygen species during iron overload. Iron mismanagement is also a key component of multiple neurodegenerative diseases and cancer. One way in which iron overload occurs is through a mutation within the HFE, high iron, gene. However, the mechanism by which HFE effects these diseases has yet to be elucidated. In this review, we consider how the HFE genotype may influence the role of macrophages and microglia (the resident macrophage of the brain) in neurodegenerative disease and cancer. Macrophages appear to redistribute their iron to parenchymal cells when an HFE mutation is present, resulting in increased vulnerability to neurodegenerative diseases and cancer through macrophage mishandling of iron.

Original languageEnglish (US)
Title of host publicationBiometals in Neurodegenerative Diseases
Subtitle of host publicationMechanisms and Therapeutics
PublisherElsevier Inc.
Pages51-66
Number of pages16
ISBN (Electronic)9780128045633
ISBN (Print)9780128045626
DOIs
StatePublished - Apr 28 2017

    Fingerprint

All Science Journal Classification (ASJC) codes

  • Medicine(all)
  • Neuroscience(all)

Cite this

Nixon, A. M., & Connor, J. R. (2017). Does HFE Genotype Impact Macrophage Phenotype in Disease Process and Therapeutic Response? In Biometals in Neurodegenerative Diseases: Mechanisms and Therapeutics (pp. 51-66). Elsevier Inc.. https://doi.org/10.1016/B978-0-12-804562-6.00004-X